Regulation of T Cell CXCL13 Production
Demographics (3)
- AGE - Age in years at enrollment (phv00541049.v1.p1)
- SEX - Biological sex (phv00541050.v1.p1)
- SEX - Biological sex (phv00541043.v1.p1)
Race and Ethnicity (1)
- RACE - Self reported race (phv00541051.v1.p1)
Other (43)
- ANALYTE_TYPE - Analyte type (phv00541073.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00541060.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00541082.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00541054.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00541068.v1.p1)
- BATCH - Batch in which samples were pooled (phv00541079.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00541072.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00541059.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00541081.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00541053.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00541067.v1.p1)
- CONDITION - Culture condition (phv00541076.v1.p1)
- CONDITION - Culture condition of ahr modulators (phv00541065.v1.p1)
- CONDITION - Treatment status before or after anifrolumab injection (phv00541084.v1.p1)
- CONDITION - Disease classification of subjects (phv00541048.v1.p1)
- CONDITION - Indication of PD-1 high, medium, or low; or whther was cultured with AHR inhibitor (CH22) or agonist (TCDD) or vehicle control (DMSO) (phv00541070.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00541042.v1.p1)
- DISEASE - Disease staus of donor (phv00541085.v1.p1)
- DISEASE - Disease status of donor (phv00541057.v1.p1)
- HASHTAG - Hastag sequence to demultiplex pooled samples (phv00541078.v1.p1)
- HASHTAG - Hastag sequence to demultiplex pooled samples (phv00541087.v1.p1)
- HASHTAG_ID - Hastag name to demultiplex pooled samples (phv00541077.v1.p1)
- HASHTAG_ID - Hastag name to demultiplex pooled samples (phv00541086.v1.p1)
- IS_TUMOR - Tumor status (phv00541074.v1.p1)
- IS_TUMOR - Tumor status (phv00541061.v1.p1)
- IS_TUMOR - Tumor status (phv00541083.v1.p1)
- IS_TUMOR - Tumor status (phv00541055.v1.p1)
- IS_TUMOR - Tumor status (phv00541069.v1.p1)
- POOL_ID - Pool ID for samples that are pooled together (phv00541046.v1.p1)
- SAMPLE_ID - Sample ID (phv00541071.v1.p1)
- SAMPLE_ID - Sample ID (phv00541058.v1.p1)
- SAMPLE_ID - Sample ID (phv00541080.v1.p1)
- SAMPLE_ID - Sample ID (phv00541052.v1.p1)
- SAMPLE_ID - Sample ID (phv00541066.v1.p1)
- SAMPLE_ID - Sample ID (phv00541045.v1.p1)
- SUBJECT_ID - Subject ID (phv00541047.v1.p1)
- SUBJECT_ID - Subject ID (phv00541041.v1.p1)
- SUBJECT_ID - Subject ID (phv00541044.v1.p1)
- TCELL_POPULTION - Sorted t cell population (phv00541056.v1.p1)
- TCELL_TYPE - Type of tcell used at onset of stimulation (phv00541063.v1.p1)
- TGF_BETA - Did the culture condition include TGFbeta (phv00541064.v1.p1)
- TIMEPOINT - Timepoint when samples were collected post stimulation (phv00541075.v1.p1)
- TIMEPOINT - Time post simulatiom (phv00541062.v1.p1)